In NASH, accumulated evidence reported that A2AR stimulation could prevent NASH development in mouse models via the multilevel inhibition of signals that cause lipotoxicity and inflammation (Imarisio et al., 2012; Zhou et al., 2019; Alchera et al., 2017). The gene discussed is ADORA2A; the disease is metabolic dysfunction-associated steatohepatitis.